The DES Center

Filter Your Results




Reva Medical's 2.5-mm Fantom Encore Bioresorbable Scaffold Receives CE Mark Approval

February 26, 2018 -- Reva Medical, Inc. announced European CE Mark approval of the 2.5-mm-diameter size of its Fantom Encore bioresorbable scaffold. The company will begi…

Lepu Medical's NeoVas Bioresorbable Scaffold Shown to Be Noninferior to Metallic Drug-Eluting Stents

February 12, 2018 -- Findings from a randomized controlled trial show that the NeoVas bioresorbable scaffold (BRS; Lepu Medical Technology (Beijing) Co., Ltd.) is noninferior …

Abbott Vascular's XIENCE 28 GLOBAL Trial Enrolls First Patient in Europe

February 12, 2018 -- Abbott Vascular announced the first patient has been enrolled in XIENCE 28 GLOBAL, a clinical trial evaluating whether patients at high risk of bleeding c…

Simplified Angiographic Approach Compared With SYNTAX Score for Left Main Coronary Artery Stenting

February 12, 2018 -- Pil Hyung Lee et al published a study online in Circulation: Cardiovascular Interventions comparing the prognostic value of Synergy Between Percutane…

BIORESOLVE-ISR Study Compares Use of BVS With DCB and EES for Coronary ISR

February 5, 2018 -- Elisabetta Moscarella, MD, et al published 1-year follow-up results from the BIORESOLVE-ISR study in Catheterization and Cardiovascular Interventions. The …

First Patient Enrolled in Postapproval Study of Tryton Side Branch Stent

January 29, 2018 -- Tryton Medical, Inc. announced that the first patient has been enrolled in the postapproval study of the company's Tryton side branch stent system for …

Biotronik's Orsiro Coronary DES Approved in Japan

January 22, 2018 -- Biotronik announced market approval for its Orsiro coronary drug-eluting stent (DES) by the Japanese Ministry of Health. The Orsiro DES features ultra-thin…

FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

January 18, 2018 -- US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, issued a statement on the agency's new policy steps for strengthening public war…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.